Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

FDA

FDA grants authorization for Novavax Covid vaccine directed against JN.1 variant

August 30, 2024
FDA authorizes Novavax Covid vaccine targeting JN.1

Introducing Novavax’s Protein-Based COVID-19 Vaccine The Food and Drug Administration (FDA) recently authorized Novavax’s updated protein-based COVID-19 vaccine for emergency use in individuals ages 12 and up. This development opens up a new option for … Read more

Categories Business News Tags authorization, covid, directed, FDA, grants, JN.1, Novavax, Vaccine, Variant

FDA Approves Updated Pfizer and Moderna KP.2 Vaccines

August 23, 2024
FDA approves Pfizer, Moderna updated KP.2 shots

Are you ready to stay ahead of the game when it comes to the latest developments in the business world? The Food and Drug Administration has given the green light for updated Covid vaccines from … Read more

Categories Business News Tags approves, FDA, KP.2, Moderna, Pfizer, Updated, Vaccines

FDA announces availability of Eli Lilly’s Zepbound and Mounjaro following shortages

August 2, 2024
Eli Lilly Zepbound, Mounjaro available after shortages, FDA says

At Extreme Investor Network, we strive to bring you the latest and most valuable information in the world of business news. Today, we are excited to share an update on Eli Lilly’s highly popular weight … Read more

Categories Business News Tags announces, Availability, Eli, FDA, Lillys, Mounjaro, shortages, Zepbound

Donanemab by Eli Lilly Receives FDA Approval for Alzheimer’s Disease

July 2, 2024
FDA approves Eli Lilly Alzheimer’s drug donanemab

Are you looking for the latest news in the business world? Well, you’ve come to the right place! At Extreme Investor Network, we pride ourselves on delivering unique and valuable information that will keep you … Read more

Categories Business News Tags Alzheimers, Approval, disease, donanemab, Eli, FDA, Lilly, Receives

Eli Lilly anticipates FDA decision on Zepbound for sleep apnea soon

June 21, 2024
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term

Extreme Investor Network is excited to share the latest news from Eli Lilly regarding their weight loss drug Zepbound. The pharmaceutical giant recently applied for U.S. approval of Zepbound for the treatment of obstructive sleep … Read more

Categories Business News Tags Anticipates, apnea, decision, Eli, FDA, Lilly, sleep, Zepbound

Merck’s pneumococcal disease vaccine for adults granted FDA approval

June 17, 2024
FDA approves Merck pneumococcal disease vaccine designed for adults

Introducing Merck’s New Pneumococcal Vaccine: Capvaxive The Food and Drug Administration recently approved Merck’s new pneumococcal vaccine, Capvaxive, designed to protect adults from a bacteria known as pneumococcus. This bacterium can cause serious illnesses and … Read more

Categories Business News Tags adults, Approval, disease, FDA, Granted, Mercks, pneumococcal, Vaccine

Jim Cramer believes that Eli Lilly has a diverse portfolio of drugs following FDA advisers’ approval of its Alzheimer’s drug

June 11, 2024
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug

Are you interested in making smart investments in the pharmaceutical industry? If so, you’ll want to keep an eye on Eli Lilly, a company that has been making waves in the healthcare world. Renowned CNBC … Read more

Categories Mad Money Tags advisers, Alzheimers, Approval, believes, Cramer, diverse, drug, drugs, Eli, FDA, Jim, Lilly, portfolio

Advisors from the FDA recommend the Alzheimer’s drug donanemab by Eli Lilly

June 10, 2024
FDA advisors recommend Eli Lilly Alzheimer's drug donanemab

Title: Eli Lilly’s Alzheimer Drug Approval Recommendation Sparks Investor Interest Introduction: Eli Lilly, a leading pharmaceutical company, has recently received a positive recommendation from a panel of independent advisors to the Food and Drug Administration … Read more

Categories Business News Tags Advisors, Alzheimers, donanemab, drug, Eli, FDA, Lilly, recommend

GSK RSV vaccine for adults aged 50-59 receives FDA approval

June 7, 2024
FDA approves GSK RSV vaccine for adults 50 to 59

Introducing GSK’s Revolutionary Vaccine Expansion to Combat RSV in Adults 50-59 Welcome to Extreme Investor Network, where we provide you with the most cutting-edge insights and updates on the latest business news. Today, we are … Read more

Categories Business News Tags adults, aged, Approval, FDA, GSK, Receives, RSV, Vaccine

FDA grants approval of Moderna’s RSV vaccine for elderly population.

May 31, 2024
FDA approves Moderna RSV vaccine for seniors

As an investor, staying informed about the latest developments in the business world is crucial for making sound financial decisions. With the recent approval of Moderna’s vaccine for respiratory syncytial virus (RSV) for adults aged … Read more

Categories Business News Tags Approval, elderly, FDA, grants, Modernas, population, RSV, Vaccine
Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 Next →

Categories

Recent Posts

  • Drew Brees Teases Possible Comeback to BroadcastingFebruary 7, 2025
  • Citi Lowers Nike Rating to Neutral Following Disappointing CEO MeetingFebruary 7, 2025
  • Jim Cramer Analyzes 10 Stocks Driving the Dow TodayFebruary 7, 2025
  • Women’s Sports Rescued | Armstrong EconomicsFebruary 7, 2025
  • Call for SEC to Back Staking in the U.S. Cryptocurrency EcosystemFebruary 7, 2025
  • DeepSeek Surge Ignites Optimism for Inexpensive Chinese Tech StocksFebruary 7, 2025
  • Crypto Market Blues: A Week of Downward TrendsFebruary 7, 2025
  • E.l.f. Beauty CEO ‘Happy’ to See Levies Set at Just 10%February 7, 2025
  • These Companies with a History of Exceeding Earnings Expectations Are Set to ReportFebruary 7, 2025
  • Roblox CEO Discusses Growth Objectives Following Earnings Report: ‘There’s a Massive Market Available’February 7, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights
Next Page »